Drug profile

The FDA adverse-event record for Unspecified Allergy Medication

19 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Allergy Medication. See the species affected, top reactions, and outcomes below.

19
adverse-event reports
5.3%
death-coded share
Dog
most-reported species
4
Emesis (multiple) - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
1
Deaths Reported
5.3%
Death Rate

Active Ingredients

Unspecified Allergy Medication

Administration Routes

UnknownOralTopicalOther

Species Affected

Dog 18
Cat 1

Most Affected Breeds

Terrier - Boston 3
Shih Tzu 2
Retriever - Labrador 2
Chihuahua 2
Domestic Shorthair 1
Maltese 1
Cattle Dog - Australian (blue heeler, red heeler, Queensland cattledog) 1
Terrier - Yorkshire 1
Hound (unspecified) 1
Terrier - Silky 1

Most Reported Reactions

Emesis (multiple) 4
Pruritus 3
Lack of efficacy (ectoparasite) - flea 3
Diarrhoea 3
Panting 3
Seizure NOS 2
Vomiting 2
Elevated liver enzymes NOS 2
Gall bladder & bile duct disorder NOS 2
Erythema (for urticaria see Immune SOC) 2
Excessive licking and/or grooming 1
Head shake - behavioural disorder 1

Outcome Breakdown

Outcome Unknown
11 (57.9%)
Ongoing
4 (21.1%)
Recovered/Normal
3 (15.8%)
Euthanized
1 (5.3%)

Unspecified Allergy Medication Adverse Event Insights

19 reports name Unspecified Allergy Medication; 1 recorded a death outcome (5.3% of reported events, not a population-level mortality rate). Active ingredient: Unspecified Allergy Medication. Administration routes: Unknown, Oral, Topical, Other.

By species: Dog (18 reports), Cat (1 reports). By breed: Terrier - Boston (3), Shih Tzu (2), Retriever - Labrador (2).

Leading clinical signs: Emesis (multiple) (4), Pruritus (3), Lack of efficacy (ectoparasite) - flea (3), Diarrhoea (3). Outcome, 19 coded reports: Outcome Unknown leads at 57.9%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.